TZIELD
NDC 73650-316, teplizumab-mzwv, injection, from Provention Bio, Inc..
- Product NDC
- 73650-316
- Status
- Listed
- Labeler
- Provention Bio, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761183
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73650-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEPLIZUMAB1 mg/mL
Pharmacologic classes
CD3-directed Antibody Interactions [MoA]; CD3-directed Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73650-316-01 | 73650031601 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73650-316-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8a39a5f-139c-4510-9777-71cbb00138faMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=73650-316
Use it
Look up 73650-316 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73650-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73650-316. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.